Bausch Health Companies Inc. (BHC)
NYSE
Closed
Oct 9, 2026
Day's Range
6.0252 wk Range
4.33Overview - BHC - Bausch Health Companies Inc.
Key Statistics
Valuation
Enterprise Value
22.22B
P/E (Trailing)
‪13.30‬
P/E (Forward)
‪1.44‬
PEG Ratio
‪0.18‬
Price / Sales (TTM)
‪0.20‬
Price / Book
‪-2.82‬
EV / EBITDA
‪5.68‬
Profitability
Gross Margin
‪72.93%‬
Profit Margin
‪-10.11%‬
Operating Margin
‪27.17%‬
Return on Assets
‪6.56%‬
Return on Equity
‪41.64%‬
Ownership
Shares Outstanding
373.90M
Float
260.57M
Short % of Shares Outstanding
‪2.88%‬
Held by Insiders
‪11.12%‬
Held by Institutions
‪65.07%‬
Price stats
Beta
‪0.37‬
50-Day Avg
‪6.21‬
200-Day Avg
‪5.76‬
Dividends
Payout Ratio
‪0.00%‬
Frequency
Quarterly
Analyst Consensus
7 analysts
Average price target
‪$ 7.50‬Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BHC - Bausch Health Companies Inc.
Peers - BHC - Bausch Health Companies Inc.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NYSE.
Profile Summary - BHC - Bausch Health Companies Inc.
About
Bausch Health Companies Inc. is a diversified specialty pharmaceutical and medical device company focused on developing, manufacturing, and marketing healthcare products across multiple therapeutic areas. Bausch Health serves the gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
